Shirley A. Millett v. HHS - Influenza, Guillain Barre Syndrome (GBS) (2024)

On July 2, 2020, Shirley A. Millett filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that she suffered Guillain-Barre Syndrome (GBS) as a result of an influenza vaccine received on October 16, 2018.

Following Ms. Millett's death on March 1, 2023, Jason Millett, as administrator of her estate, was substituted as the petitioner.

The petitioner alleged that the vaccine was administered in the United States, that Ms. Millett's GBS persisted for more than six months, and that neither Ms.

Millett nor any other party had previously filed an action or received compensation for her vaccine-related GBS. The respondent denied that the flu vaccine caused Ms.

Millett's alleged GBS, its residual effects, or her death. On January 5, 2024, the parties filed a joint stipulation agreeing to settle the case and award compensation.

Chief Special Master Brian H. Corcoran reviewed the stipulation, found it reasonable, and adopted it as his decision.

Pursuant to the stipulation, a lump sum of $100,000.00 was awarded to the estate of Shirley A. Millett, payable to Jason Millett as Administrator.

This amount was intended as compensation for all items of damages available under Section 15(a) of the Vaccine Act. The decision was issued on January 8, 2024.

Petitioner counsel was Bobbie L. Flynt of Crandall & Pera Law, LLC, and respondent counsel was Nina Ren of the U.S.

Department of Justice.